With politicians touting the potential benefits of malaria drugs to fight COVID-19, some people are turning away from clinical trials of other therapies. People with COVID-19 who arrive at the Salvador Zubirán National Institute of Medical Sciences and Nutrition in Mexico City to search for treatment can choose from a menu of clinical trials, carefully...
by Lancet The first study to report use of the rheumatoid arthritis drug anakinra to treat COVID-19 patients found that high-dose anakinra was safe and was associated with respiratory improvements and reduced signs of cytokine storm in 72% (21/29) of patients, according to results from patients studied for 21 days (enrolled from 17 to 27...
Boston, Mass. — Since the World Health Organization declared COVID-19 a Public Health Concern of Global Interest on January 30, more than one million have tested positive for the illness in the United States, and more than 62,000 have died. With no FDA-approved treatments available to date, the anti-malarial drug, hydroxychloroquine, has emerged as a...
by European League Against Rheumatism (EULAR) The current outbreak of COVID-19 represents a source of concern for the management of systemic lupus erythematous, SLE, patients. These patients have an increased risk of severe infections due to their underlying disease, the use of immunosuppressive drugs, as well as the potential presence of organ damage associated with...
PHARMACY experts at the University of Huddersfield are urging caution over claims that widely-available antimalarial drugs could be a “magic bullet” to prevent and cure CoVid-19. And the medicines can – if used rashly – have serious side effects. Although there have been some encouraging signs from small-scale preliminary trials of the drugs chloroquine (CQ)...
by Adam M. Brufsky, The Conversation Sugar is not only something that sweetens our food. It is also something that is an essential part of the proteins that make up our bodies. That led me to believe, as I wrote in the Journal of Medical Virology, that control of blood glucose by diet and exercise,...
With 368 patients, the study is the largest look so far of hydroxychloroquine with or without the antibiotic azithromycin for Covid-19. A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals. There were more deaths among those...
by Katherine Seley-Radtke, The Conversation On Saturday the Food and Drug Administration approved the use of two antimalarial drugs, hydroxychloroquine and a related medication, chloroquine, for emergency use to treat COVID-19. The drugs were touted by President Trump as a “game changer” for COVID-19. However, a study just published in a French medical journal provides...
This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson, coming at you once again from isolation. Please excuse the webcam. Coronavirus has caused us to reevaluate so many things. I’m doing renal consults today from my office, only...
